0001213900-21-046687.txt : 20210903
0001213900-21-046687.hdr.sgml : 20210903
20210903170411
ACCESSION NUMBER: 0001213900-21-046687
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210901
FILED AS OF DATE: 20210903
DATE AS OF CHANGE: 20210903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Berger Mark Stanley
CENTRAL INDEX KEY: 0001700283
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36374
FILM NUMBER: 211237297
MAIL ADDRESS:
STREET 1: 140 RIVERSIDE DRIVE
STREET 2: APT. 9K
CITY: NEW YORK
STATE: NY
ZIP: 10024
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Actinium Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001388320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 880378336
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 275 MADISON AVENUE, 7TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: 646-677-3875
MAIL ADDRESS:
STREET 1: 275 MADISON AVENUE, 7TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
FORMER COMPANY:
FORMER CONFORMED NAME: Cactus Ventures, Inc.
DATE OF NAME CHANGE: 20070130
4
1
ownership.xml
OWNERSHIP DOCUMENT
X0306
4
2021-09-01
0
0001388320
Actinium Pharmaceuticals, Inc.
ATNM
0001700283
Berger Mark Stanley
C/O ACTINIUM PHARMACEUTICALS, INC.,
275 MADISON AVENUE, 7TH FLOOR
NEW YORK,
NY
10016
0
1
0
0
Chief Medical Officer
Stock Option (Right to Buy)
6.07
2021-09-01
4
A
0
67164
0
A
2031-09-01
Common Stock
67164
67164
D
This price represents the closing price of the Company's common stock on the date of the board of directors approval of the grant.
Pursuant to the terms of the Company's Amended and Restated 2013 Stock Plan and 2019 Stock Plan, 2% of the options will vest each month from September 1, 2021 until fully vested.
/s/ Mark Berger
2021-09-03